COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 1948: Articles 19471-19480  | Next

Indicators of COVID-19 status in a cohort study of university staff and post-graduate research students, including results from home antibody testing
Davis, K. A. S., Carr, E., Leightley, D., Vitiello, V., Cartwright, G. B., Lavelle, G., Wickersham, A., Malim, M. H., Oetzmann, C., Polling, C., Stevelink, S. A. M., Razavi, R., Hotopf, M., KCL-CHECK research team
10.1101/2020.12.07.20245183 — Posted: 2020-12-07
A new, simple method of describing COVID-19 trajectory and dynamics in any country based on Johnson Cumulative Distribution Function fitting.
Cmiel, A. M., Cmiel, B.
10.1101/2020.12.05.20244178 — Posted: 2020-12-07
Selectively caring for the most severe COVID-19 patients delays ICU bed shortages more than increasing hospital capacity
Roberts, M. D., Seymour, H. D., Dimitrov, A.
10.1101/2020.12.05.20222968 — Posted: 2020-12-07
Seroconversion stages COVID19 into distinct pathophysiological states
Galbraith, M. D., Kinning, K. T., Sullivan, K. D., Baxter, R., Araya, P., Jordan, K. R., Russell, S., Smith, K. P., Granrath, R. E., Shaw, J. R., Dzieciatkowska, M., Ghosh, T., Monte, A. A., D'Alessandro, A., Hansen, K. C., Bennett, T. D., Hsieh, E. W. Y., Espinosa, J. M.
10.1101/2020.12.05.20244442 — Posted: 2020-12-07
Sensitive detection and quantification of SARS-CoV-2 in saliva
Abasiyanik, M. F., Flood, B., Lin, J., Ozcan, S., Rouhani, S., Pyzer, A., Trujillo, J., Zhen, C., Wu, P., Jumic, S., Wang, A., Gajewski, T., Wang, P., Hartley, M., Ameti, B., Niemiec, R., Fernando, M., Aydogan, B., Bethel, C., Matushek, S., Beavis, K., Agrawal, N., Segal, J., Tay, S., Izumchenko, E.
10.1101/2020.12.04.20241059 — Posted: 2020-12-07
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Young, M. K., Kornmeier, C., Carpenter, R. M., Natale, N. R., Sasson, J. M., Solga, M. D., Mathers, A. J., Poulter, M. D., Qiang, X., Petri, W. A.
10.1101/2020.12.05.20244541 — Posted: 2020-12-07
Diagnostic and monitoring utilities of saliva for SARS-CoV-2
Abdulrahman, A., Albastaki, A., AlAwadhi, A. I., AlWazzan, A., AlQahtani, M.
10.1101/2020.12.07.20244681 — Posted: 2020-12-07
Evaluation of a SARS-CoV-2 rapid antigen test: potential to help reduce community spread?
Toptan, T., Eckermann, L., Pfeiffer, A. E., Hoehl, S., Ciesek, S., Drosten, C., Corman, V. M.
10.1101/2020.12.04.20240283 — Posted: 2020-12-07
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
Dugas, M., Grote-Westrick, T., Merle, U., Fontenay, M., Kremer, A. E., Vollenberg, R., Lorentzen, E., Tiwari-Heckler, S., Duchemin, J., Ellouze, S., Vetter, M., Fuerst, J., Brix, T., Denkinger, C. M., Mueller-Tidow, C., Schmidt, H., Tepasse, P.-R., Kuehn, J.
10.1101/2020.12.07.20245241 — Posted: 2020-12-07
Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR.
Olearo, F., Noerz, D., Heinrich, F., Sutter, J. P., Roedel, K., Schultze, A., Schulze Zur Wiesch, J., Braun, P., Oesterreich, L., Kreuels, B., Wichmann, D., Aepfelbacher, M., Pfefferle, S., Luetgehetmann, M.
10.1101/2020.12.05.20244673 — Posted: 2020-12-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).